Caplight Directory>Investors>MVM Life Science Partners LLP>Mvm-life-science-partners-llp


MVM Life Science Partners LLP

MVM Life Science Partners LLP

Londonmvmp.com

Overview

MVM Life Science Partners LLP is a global venture capital and private equity firm founded in 1997 that invests in the healthcare and life sciences sectors, including medical technology, pharmaceuticals, diagnostics, and digital health.

Year Founded

1997

Portfolio Companies

18

Website

mvmp.com

Investments

CompanyDateStageLead
Neurent MedicalFeb 2026Series CLead
Avanzanite BioscienceNov 2025Series ALead
ProVerum MedicalAug 2025Series BLead
GT Medical TechnologiesJul 2025Series DCo-investor
Vital ConnectFeb 2025Series GCo-investor
View all investments

Key People

Stephen Reeders

Founding Partner, MVM Partners

Akhilesh Pathipati

Partner

Eric Fritz

Partner

Hugo Harrod

Partner

Jack Tanaka

Partner

Kevin Cheng

Partner

Kyle Dempsey

Partner

Isabella Mihov

Investor

Talia Kirschbaum

Healthcare Investor

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon
Year Founded1997

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.